Author

M. A. Tejani

Observed name: Tejani, M. A.

OpenAlex ID: A5049020845

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

2020 · Cohen, D. J., Jimeno, A., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Works count: 1

Citation count:

H-index:

I10-index: